NCT05951712View on ClinicalTrials.gov

Pre-medication With N-acetylcysteine and Simethicone to Improve Mucosal Visibility During Gastroduodenoscopy

NACompletedINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

June 16, 2022

Primary Completion Date

August 20, 2022

Study Completion Date

November 4, 2022

Conditions
Mucosal Erosion
Interventions
DRUG

Simethicone 150mg

Impact of simethicone on the mucosal visibility of stomach and duodenum

DRUG

N Acetyl cysteine 600mg

Impact of N Acetyl cysteine on the mucosal visibility of stomach and duodenum

DRUG

Simethicone 150mg plus N Acetyl cysteine 600 mg

Impact of simethicone plus N Acetyl cysteine on the mucosal visibility of stomach and duodenum

OTHER

Placebo

Impact of water on the mucosal visibility of stomach and duodenum

Trial Locations (1)

500079

Asian institute of Gastroenterology, Hyderabad

All Listed Sponsors
lead

Asian Institute of Gastroenterology, India

OTHER